27 February 2020
DEMECAN signs binding supply agreement with Australia-based medical cannabis producer

DEMECAN announces the signing of a three-year supply agreement with Australian-based medical cannabis producer, Little Green Pharma, marking yet another milestone in DEMECAN’s path to guarantee a consistent supply of pharmaceutical grade cannabis to patients in Germany. The agreement is for an annual amount of at least 1,000 kg of dried flower or 48,000 units […]

24 February 2020
DEMECAN receives approval for the distribution of cannabis flowers from the Netherlands

DEMECAN is pleased to announce receipt of AmRadV approval from the German cannabis agency, marking the start of cannabis flower sales from the Netherlands. The flowers, manufactured by Bedrocan, are sold exclusively for medical purposes through pharmacies. The AmRadV regulates the sale of medicinal products treated with ionizing radiation to protect patients from bacteria, mold, […]

4 October 2019
btov and Single Family Office Invest in German Cannabis: 7 Million Euros for DEMECAN

The btov Private Investor Network and a German Single Family Office invest in DEMECAN DEMECAN is the first German producer of medical cannabis Berlin, October 01, 2019 – DEMECAN has completed a Series A financing round of 7 million euros. The funding will be used to expand the production facility for medical cannabis and the […]

23 May 2019
DEMECAN Confirms Award for German Medical Cannabis Production

BERLIN, May 27, 2019 DEMECAN Holding GmbH [“DEMECAN” or “The Company”] today announced that its subsidiary, DEMECAN GmbH, has been officially selected to cultivate medicinal cannabis in Germany by the Federal Institute for Drugs and Medical Devices (“BfArM”). DEMECAN GmbH was awarded three of thirteen lots of domestic cannabis production, making it one of only […]